(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 35.72% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 119.14%.
Neuronetics's revenue in 2025 is $111,106,000.On average, 1 Wall Street analysts forecast STIM's revenue for 2025 to be $9,970,961,608, with the lowest STIM revenue forecast at $9,970,961,608, and the highest STIM revenue forecast at $9,970,961,608.
In 2026, STIM is forecast to generate $10,977,381,368 in revenue, with the lowest revenue forecast at $10,977,381,368 and the highest revenue forecast at $10,977,381,368.